breast cancer market Deals, Supply and Utilization 2017 Investigation and Figures to 2023

The report for global breast cancer market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. 

The global breast cancer market is expected to grow at a CAGR of 9.2% during forecasted period 2017-2023.

Brest cancer is type of cancer developed in breast tissue. Formation of lump in a breast, red patches on the skin are the some of the common symptoms of the breast cancer. Obesity, lack of physical exercise, overexposure to radiation and drinking alcohol are some of the risk factor for developing breast cancer. According to WHO, it is the second most common type of cancer in women. Every year 200,000 new cases are diagnosed worldwide and this number is continuously increasing. Prevalence of breast cancer is more common in developed countries compare with developing countries. Increasing number of females suffering from breast cancer is the major factor for the growth of market. Beside this adoption of unhealthy lifestyle, increasing female geriatric population, exposure to harmful radiation and increasing governmental initiatives also contributed in the growth of the market. As no absolute treatment is available there is a scope for developing the market across the world. While on other hand high cost of the treatment, adverse effects associated with the therapy and long approval time for the drugs are responsible for restraining the growth of the market.

Get Sample copy at https://www.marketresearchfuture.com/sample_request/1379 .

Key players for global breast cancer market

Pfizer (US), Novartis AG (Switzerland), Oncogenex (US), Apthera Inc (UK), BioNumerik Pharmaceuticals (US), Oncothyreon Inc (US), Astellas (Japan), Bipar Sciences (US), Puma Biotechnology (US), Sanofi S.A. (US), Eli Lilly and Company (US), AstraZeneca (UK), F. Hoffmann-La Roche (Switzerland), GlaxoSmithKline (UK), Genentech (US), Teva Pharmaceutical Industries (Israel), Sun Pharmaceutical Industries Ltd (India), Accord Healthcare, Inc. (India), Gilead Sciences, Inc. (US), Bristol-Myers Squibb company (US), Actavis, Inc. (US), Hospira, Inc. (US), Bayer AG (Germany)

Segmentation

Global breast cancer market is segmented on the basis of type into invasive ductal carcinoma, invasive lobular carcinoma and other. On the basis of treatment they are segmented into chemotherapy, surgery & radiation therapy, targeted therapy, biologic therapy, hormone therapy and other. Chemotherapy is further segmented into antimetabolites, anthracyclines, taxanes and alkylating agents. Target therapy is further segmented into tyrosine kinase inhibitors and monoclonal antibodies Hormone therapy is further segmented into selective estrogen-receptor modulators (SERMs), aromatase inhibitors and others. On the basis of end users the market is segmented into hospital pharmacies, private pharmacies and other.

Regional analysis

On regional basis, global breast cancer market is dominated by America. Changing lifestyle and increasing prevalence of breast cancer in America has driven the growth of the market. America breast cancer market is followed by Europe. Technological advances, increased life expectancy and healthcare expenditure of people is responsible for the growth of this market in America and Europe. Asia Pacific is expecting a fastest growth for the market.

TABLE OF CONTENTS

1    INTRODUCTION  

      1.1    DEFINITION  

      1.2    SCOPE OF STUDY  

            1.2.1    RESEARCH OBJECTIVE  

            1.2.2    ASSUMPTIONS & LIMITATIONS  

                1.2.2.1    ASSUMPTIONS  

                1.2.2.2    LIMITATIONS  

      1.3    MARKET STRUCTURE:  

2    RESEARCH METHODOLOGY  

      2.1    RESEARCH PROCESS:  

      2.2    PRIMARY RESEARCH  

      2.3    SECONDARY RESEARCH:  

3    MARKET DYNAMICS  

      3.1    DRIVERS  

      3.2    RESTRAINTS      

      3.3    OPPORTUNITIES  

      3.4    MACROECONOMIC INDICATORS  

4    MARKET FACTOR ANALYSIS  

      4.1    PORTERS FIVE FORCES MODEL  

      4.2    BARGAINING POWER OF SUPPLIERS  

      4.3    BARGAINING POWER OF BUYERS  

      4.4    THREAT OF NEW ENTRANTS  

      4.5    THREAT OF SUBSTITUTES  

      4.6    INTENSITY OF RIVALRY  

5.    GLOBAL BREAST CANCER MARKET, BY TYPE

….Continued

Get discount at https://www.marketresearchfuture.com/check-discount/1379 .

The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand,

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com